Found 280 matching trials
H3N2 M2SR in Pediatric Population
PHASE1This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Location
Saint Louis University - Center for Vaccine Development
Immune Boost In Non-Small Cell Lung Cancer
NAInsufficient migration and activation of tumour specific effector T cells s...
Location
Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg
S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
PHASE2RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
PHASE1Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...
Location
University of Miami
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients
PHASE2Sinonasal tumors are rare diseases, as they account for the 0.2 % - 0.8 % o...
Location
Presidio Ospedaliero Spedali Civili di Brescia
Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD
PHASE2This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District
PHASE2Nowadays the association between radiotherapy and the anti- Epidermal Growt...
Location
Division of Radiotherapy European Institute of Oncology
Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer
PHASE1This will be the first study to assess the clinical feasibility of dose esc...
Location
Saint Bartholomew's Hospital
Intra-lesional Tumor Boost for Bulky Cervical Cancer
PHASE2The goal of this clinical trial is to learn if adding a radiation boost (in...
Location
Seoul National University Bundang Hospital
Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy
PHASE2Phase II multicenter prospective study on the safety of eliminating surgery...
Location
Tianjin medical university cancer institute and hospital